Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Pediatric Acute Promyelocytic Leukemia in Brazil: Epidemiology, Molecular Features, and Importance of GST-Theta 1 in Chemotherapy Response and Outcome

Francianne G. Andrade, MSc, PhD, Suellen V. M. Feliciano, MSc, PhD, Ingrid Sardou-Cezar, Gisele D. Brisson, MSc, Filipe V. S. Bueno, MSc, Danielle T. Vianna, MD MSc, Eugênia Terra-Granado, MSc, PhD, Ilana Z. Renault, Marceli O. Santos, MSc, PhD, Elda P. Noronha, MSc, PhD, Joseph L. Wiemels, PhD, Maria S. Pombo-de-Oliveira, MD PhD

Blood (2019) 134 (Supplement_1): 5187.

https://doi.org/10.1182/blood-2019-131529

Published: 2019

Journal Articles

Molecular Epidemiology of Acute Myeloid Leukemia (AML): Novel Association of Clinical Epidemiologic Exposures with Unique Mutation Groups on Exome Sequencing of Leukemia DNA in the Mayo Clinic AML Epidemiology Cohort

James M. Foran, MD, Michael Heckman, MS, Rhett P. Ketterling, MD, Lisa Sproat, MD MSW, Liuyan Jennifer Jiang, MD, Bruce Eckloff, PhD, Nancy Diehl, Laura E. Finn, MD, Keith Robertson, PhD, Raoul Tibes, MD PhD, James R. Cerhan, MD PhD, Yan W Asmann, PhD

Blood (2017) 130 (Supplement 1): 570.

https://doi.org/10.1182/blood.V130.Suppl_1.570.570

Published: 2017

Journal Articles

Evaluation of the NCCN-IPI As a Prognostic Tool in PTCLs

Fredrik Ellin, MD MSc, Matthew J Maurer, MS, Line Srour, MD, Umar Farooq, MD, Mats Jerkeman, MD PhD, Joseph M Connors, MD, Karin E Smedby, MD PhD, Nabila Nora Bennani, MD, Stephen M Ansell, MD PhD, Graham W Slack, MD, James R. Cerhan, MD PhD, Thomas Relander, MD PhD, Andrew L Feldman, MD, Kerry J Savage, BSc, MD MSc

Blood (2017) 130 (Supplement 1): 2795.

https://doi.org/10.1182/blood.V130.Suppl_1.2795.2795

Published: 2017

Journal Articles

Unique Clinical Epidemiologic Risk Factors Are Associated with Distinct Methylation Subgroups in Newly-Diagnosed Acute Myeloid Leukemia (AML)

Amanda Shreders, MD, Michael Heckman, Dan Zhou, PhD, Man Yang, PhD, Laura E. Finn, MD, Lisa Sproat, MD MSW, Liuyan Jiang, MD, Nancy Diehl, Ryan Hlady, Rhett P. Ketterling, MD, Raoul Tibes, MD PhD, Keith D Robertson, PhD, James M. Foran, MD

Blood (2016) 128 (22): 1719.

https://doi.org/10.1182/blood.V128.22.1719.1719

Published: 2016

Journal Articles

Rates and Outcomes of Follicular Lymphoma Transformation in the Rituximab Era: A Report From the University of Iowa/Mayo Clinic SPORE Molecular Epidemiology Resource

Brian K Link, MD, Matthew J Maurer, MS, Grzegorz S. Nowakowski, MD, Stephen M Ansell, MD, PhD, William R Macon, MD, Sergei I Syrbu, MD, Susan L Slager, PhD, Carrie A. Thompson, MD, David J. Inwards, MD, Patrick B. Johnston, MD, PhD, Joseph P. Colgan, MD, Thomas E. Witzig, MD, George J Weiner, Thomas M. Habermann, James R Cerhan, MD, PhD

Blood (2012) 120 (21): 1546.

https://doi.org/10.1182/blood.V120.21.1546.1546

Published: 2012

Journal Articles

CXCR5 Polymorphisms in Non-Hodgkin Lymphoma (NHL) Risk and Prognosis.

Bridget Charbonneau, PhD, MPH, Alice H Wang, BA, Anne J. Novak, Ph.D., Stephen M. Ansell, M.D., Ph.D., Andrew L. Feldman, MD, Yan W Asmann, PhD, Julie M Cunningham, PhD, Matthew J Maurer, MS, Ahmet Dogan, MD, PhD, Thomas M Habermann, MD, Brian K Link, MD, Susan L Slager, PhD, James R Cerhan, MD, PhD

Blood (2012) 120 (21): 2702.

https://doi.org/10.1182/blood.V120.21.2702.2702

Published: 2012

Journal Articles

Non-Follicular Low Grade B-Cell Lymphomas: Patterns of Presentation and Management with Comparative Prognostic Utility of IPI and FLIPI

Laura S. Jacobus, MS, Julianne Lunde, MA, Matthew J Maurer, MS, Ahmet Dogan, MD, PhD, Sergei I Syrbu, MD, Cristine Allmer, Anne J. Novak, Ph.D., James R Cerhan, MD, PhD, Grzegorz S. Nowakowski, MD, Susan L Slager, PhD, Thomas E. Witzig, MD, Carrie A. Thompson, MD, George J. Weiner, MD, Thomas M Habermann, MD, Stephen M. Ansell, M.D., Ph.D., Brian K Link, MD

Blood (2012) 120 (21): 1563.

https://doi.org/10.1182/blood.V120.21.1563.1563

Published: 2012

Journal Articles

Molecular Epidemiology of β-Thalassemia in Pakistan: Far Reaching Implications

Saqib Hussain Ansari, MBBS, MSc, Tahir S Shamsi, MD, Muneera Bohray, Mohammed Tahir Khan, MBBS, MS, Tasneem Farzana, Kousar Perveen, Sajida Erum

Blood (2011) 118 (21): 5309.

https://doi.org/10.1182/blood.V118.21.5309.5309

Published: 2011

Journal Articles

Functional Oncogene Identification in Patient Leukemia Samples.

Akinori Yoda, Ph.D., Martin Sattler, PhD, David M Weinstock, MD

Blood (2008) 112 (11): 1790.

https://doi.org/10.1182/blood.V112.11.1790.1790

Published: 2008

Journal Articles

Effective Containment of Human Respiratory Syncytial Virus Infections in a Bone Marrow Transplantation Program Resulting from the Combined Implementation of Molecular Epidemiology, Infection Control, and Early Treatment Strategies.

Steven S. Cha, MD, Monic J. Stuart, MD, Susan Poutanen, MD, Sasha Madison, MD, Ellen Jo Baron, MD, Dean Erdman, MD, Janice M. Brown, MD.

Blood (2004) 104 (11): 2225.

https://doi.org/10.1182/blood.V104.11.2225.2225

Published: 2004

NARROW

Pediatric Acute Promyelocytic Leukemia in Brazil: Epidemiology, Molecular Features, and Importance of GST-Theta 1 in Chemotherapy Response and Outcome

Molecular Epidemiology of Acute Myeloid Leukemia (AML): Novel Association of Clinical Epidemiologic Exposures with Unique Mutation Groups on Exome Sequencing of Leukemia DNA in the Mayo Clinic AML Epidemiology Cohort

Evaluation of the NCCN-IPI As a Prognostic Tool in PTCLs

Unique Clinical Epidemiologic Risk Factors Are Associated with Distinct Methylation Subgroups in Newly-Diagnosed Acute Myeloid Leukemia (AML)

Rates and Outcomes of Follicular Lymphoma Transformation in the Rituximab Era: A Report From the University of Iowa/Mayo Clinic SPORE Molecular Epidemiology Resource

CXCR5 Polymorphisms in Non-Hodgkin Lymphoma (NHL) Risk and Prognosis.

Non-Follicular Low Grade B-Cell Lymphomas: Patterns of Presentation and Management with Comparative Prognostic Utility of IPI and FLIPI

Molecular Epidemiology of β-Thalassemia in Pakistan: Far Reaching Implications

Functional Oncogene Identification in Patient Leukemia Samples.

Effective Containment of Human Respiratory Syncytial Virus Infections in a Bone Marrow Transplantation Program Resulting from the Combined Implementation of Molecular Epidemiology, Infection Control, and Early Treatment Strategies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only